The Patent Process - By Keltie (Video)

The High Court examined whether an events company's use of prestigious brand names like VANITY FAIR and GQ on its website constituted trade mark infringement and passing off. The case centered on whether promotional references to exclusive invitation-only events crossed the line from legitimate identification to misleading consumers about a commercial connection with the trade mark owner.

For companies developing advanced materials, battery technologies, and green technologies, the journey from laboratory proof-of-concept to commercial manufacturing often reveals the most valuable patentable inventions. Scale-up challenges involving heat transfer, particle morphology, coating uniformity, and manufacturing economics can create intellectual property that proves more commercially significant than the original laboratory discovery.

Sustainability is no longer a niche concern within the cosmetics and skincare sector. Increasingly, brands are being challenged by consumers, retailers and regulators to reduce waste and demonstrate meaningful environmental credentials.

The European Patent Office Board of Appeal has issued a surprising judgment demonstrating how adding a manufacturing step to a computer-aided design method can paradoxically extend patent scope post-grant. This case explores the intricate relationship between process claims and product protection under Article 64(2) EPC...

A UK court has ruled on the validity of Novartis's supplementary protection certificate for Entresto, examining whether the SPC product should be defined as the specific co-complex formulation or the broader...

James May has partnered with Dorset brewer Hall & Woodhouse to launch The Spanner, a traditional cask ale that raises intriguing questions about trade mark strategy in the food and drink sector. From choosing a distinctive name to navigating ownership in celebrity collaborations, this new beer demonstrates why proper trade mark protection matters before a brand goes to market.

For venture-backed biotech companies, intellectual property strategy must be designed from the outset with the end goal in mind. This article explores how aligning IP decisions with future acquirer expectations, understanding exit scenarios, and building defensible patent portfolios can dramatically increase both the probability and value of successful exits in the life sciences sector.

As nuclear fusion technology moves closer to commercial viability, a critical question emerges: should patent protection be extended when mandatory regulatory processes consume years of the standard 20-year patent term? This analysis examines whether the patent system adequately incentivizes investment in fusion energy, where foundational inventions may expire just as they become commercially deployable.

The UK Patents Court has upheld Novartis' patent and SPC protecting Entresto, its blockbuster heart failure treatment combining valsartan and sacubitril, rejecting all validity challenges from generic manufacturer Accord Healthcare. The judgment provides crucial guidance on plausibility requirements where experimental data have been generated but not fully disclosed in the patent specification, clarifying when qualitative disclosure of positive results suffices without detailed numerical data.

The ongoing commercial rivalry between fast-fashion giants Shein and Temu has evolved into one of the most significant intellectual property disputes in the e-commerce sector. This landmark case examines critical questions about copyright ownership, platform liability, and the legal responsibilities of online marketplaces in the digital age.